| Product ID |
Structure |
Product Name |
Purity |
Price |
Delete |
| AS-1204 |
 |
(S,S)-2,8-Diazabicyclo[4,3,0]nonane |
98%
|
|
Delete |
| AS-8488 |
 |
1H-PYRROLO[2,3-B]PYRIDINE-4-CARBOXYLIC ACID |
98%
|
|
Delete |
| AS-8785 |
 |
2,6-Dibromo-4-methylpyridine |
98%
|
|
Delete |
| AS-9085 |
 |
2-(3-BROMOPHENOXY)TETRAHYDRO-2H-PYRAN |
98%
|
|
Delete |
| AS-7451 |
 |
2-[2-(2-CHLOROETHOXY)ETHOXY]ETHANOL |
98%
|
|
Delete |
| AS-9101 |
 |
2-CHLORO-4,5-DIAMINOPYRIMIDINE |
98%
|
|
Delete |
| AS-6996 |
 |
2-Fluoro-2',3',5'-triacetoxyadenosine |
98%
|
|
Delete |
| AS-7442 |
 |
2-Fluoro-3-Bromo-5-Aminopyridine |
98%
|
|
Delete |
| AS-6995 |
 |
2-Iodoacetamide |
98%
|
|
Delete |
| AS-7448 |
 |
2-METHOXYETHYLAMINE |
98%
|
$108/25g, $348/100g, $798/250g, $1280/500g, $2180/1kg, bulky available |
Delete |
| AS-7453 |
 |
2-Pyridinol-1-oxide |
98%
|
|
Delete |
| AS-3268 |
 |
4-(Trifluoromethoxy)benzyl chloride |
98%
|
|
Delete |
| AS-3269 |
 |
4-(Trifluoromethoxy)phenyl isocyanate |
98%
|
|
Delete |
| AS-3266 |
 |
4-(Trifluoromethoxy)phenylhydrazine hydrochloride |
98%
|
|
Delete |
| AS-6908 |
 |
4-Chlorophenoxyacetic acid |
98%
|
|
Delete |
| AS-3271 |
 |
4-tert-Butylbenzyl bromide |
98%
|
|
Delete |
| AS-7447 |
 |
5-BROMO-2-METHOXY-4-METHYLPYRIDINE |
98%
|
|
Delete |
| AS-1203 |
 |
6-BENZYL-5,7-DIOXO-OCTAHYDROPYRROLO[3,4-B] PYRIDINE |
98%
|
|
Delete |
| AS-8482 |
 |
6-Quinolinecarboxylic acid |
98%
|
|
Delete |
| AS-7115 |
 |
AKOS B033273 |
98%
|
|
Delete |
| AS-1209 |
 |
Citraconic anhydride |
98%
|
|
Delete |
| AS-8498 |
 |
D-(+)-CHIRO-INOSITOL |
98%
|
|
Delete |
| AS-1210 |
 |
Di-tert-Butyl azodicarboxylate |
98%
|
|
Delete |
| AS-1211 |
 |
Diethyl azodicarboxylate |
98%
|
|
Delete |
| AS-6897 |
 |
FMOC-HOMOCYS(TRT)-OH |
98%
|
|
Delete |
| AS-8485 |
 |
Methyl 6-bromo-2-naphthoate |
98%
|
|
Delete |
| AS-7452 |
 |
Pyridine-2-carboximidamide hydrochloride |
98%
|
|
Delete |
| AS-7113 |
 |
Silane, (difluoroMethyl)triMethyl- |
98%
|
|
Delete |
| AS-6903 |
 |
Thymolphthalein |
98%
|
|
Delete |
|
Continue browsing products
Quote/Order
Inquiry
|